Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19F

Patent No. EP3576759 (titled "Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19F") was filed by Merck Sharp & Dohme on Jan 30, 2018. The application was issued on Sep 24, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANOFI VACCINESJun 24, 2026ZWICKER
SK BIOSCIENCEJun 24, 2026ZWICKER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3576759

MERCK SHARP & DOHME
Application Number
EP18747138A
Filing Date
Jan 30, 2018
Status
Granted And Under Opposition
Aug 22, 2025
Publication Date
Sep 24, 2025